Author:
Husni M. Elaine,Mease Philip J.
Publisher
Springer Science and Business Media LLC
Reference37 articles.
1. • Eder L, Zisman D, Barzilai M, et al.: Subclinical atherosclerosis in psoriatic arthritis: a case-control study. J Rheumatol 2008, 35:877–882. This was a small case-control study that recently highlighted the increased prevalence of subclinical atherosclerosis, concentrating on PsA patients.
2. •• Tam LS, Tomlinson B, Chu TT, et al.: Cardiovascular risk profile of patients with psoriatic arthritis compared to controls—the role of inflammation. Rheumatology (Oxford) 2008, 47:718–723. This excellent controlled study adjusted for both traditional and novel CV risk factors that may affect PsA patients and CV disease. It provides a logical framework of the multitude of CV risk factors that can be involved and need to be adjusted to provide a comprehensive picture of PsA and CV risk.
3. • Ciocon DH, Horn EJ, Kimball AB: Quality of life and treatment satisfaction among patients with psoriasis and psoriatic arthritis and patients with psoriasis only: results of the 2005 spring US National Psoriasis Foundation survey. Am J Clin Dermatol 2008, 9:111–117. This was an important study that highlights quality-of-life and treatment satisfaction issues. It was conducted in association with the National Psoriasis Foundation.
4. Gelfand JM, Neimann AL, Shin DB, et al.: Risk of myocardial infarction in patients with psoriasis. JAMA 2006, 296:1735–1741.
5. Gladman DD: Mortality in psoriatic arthritis. Clin Exp Rheumatol 2008, 26(5 Suppl 51):S62–S65.
Cited by
31 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献